Insomnia
📧 Sign up to get email alerts when something new happens for Insomnia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-11-15Clinical Trial Update: Young Adult and Teen Sleep Study [Phase 2]
A Phase 2 sleep study sponsored by Kaiser Permanente in young adults and teens has completed.
-
CLINICAL_TRIALS trial_result · 2012-11-12Clinical Trial Update: Study of Efficacy of Ramelteon in Adults With Chronic Insomnia [Phase 3]
A Phase 3 trial evaluating ramelteon in adults with chronic insomnia has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: Time to Remission of Depressive Symptoms With Combined SSRI and Ramelteon [Phase 3]
Phase 3 trial investigating combined SSRI and ramelteon for time to remission of depressive symptoms in major depressive disorder with insom…
-
CLINICAL_TRIALS trial_result · 2012-10-22Clinical Trial Update: Twelve Month Study of the Safety of Eszopiclone in Adult Subjects With Insomnia [Phase 3]
A Phase 3 twelve-month safety study of eszopiclone in adults with primary insomnia has completed, summarizing its safety findings.
-
CLINICAL_TRIALS trial_result · 2012-10-17Clinical Trial Update: Treatment of Insomnia Secondary to Chronic Pain [NA]
A completed clinical trial at the University of Rochester evaluated treatment of insomnia associated with chronic pain, with results posted …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-10-17Clinical Trial Update: The Psychoneuroimmunology of Insomnia
This entry notes the completion of a clinical trial investigating the psychoneuroimmunology of insomnia and that its results were posted in …
-
CLINICAL_TRIALS trial_result · 2012-10-15Clinical Trial Update: Trazodone for Sleep Disorders in Alzheimer's Disease [Phase 3]
A Phase 3 trial evaluating trazodone for sleep disorders in Alzheimer's disease has completed. The document does not report the trial result…
-
FDA approval · 2012-10-10FDA Approved: LUNESTA — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for LUNESTA (eszopiclone) submitted by Waylis Therapeutics LLC.
-
CLINICAL_TRIALS trial_result · 2012-10-03Clinical Trial Update: Eszopiclone Co-Administered With Escitalopram for Insomnia in Elderly Adults With Major Depressive Disorder [Phase 4]
Phase 4 trial update evaluating safety and outcomes of co-administering eszopiclone with escitalopram for insomnia in elderly adults with ma…
-
CLINICAL_TRIALS research · 2012-09-21Clinical Trial Update: Long-term Follow-up of Functional Performance and Exercise Efficacy in Community-dwelling Elderly With Insomnia [NA]
This clinical trial update covers long-term follow-up on functional performance and the efficacy of exercise in community-dwelling elderly w…
-
CLINICAL_TRIALS trial_result · 2012-09-20Clinical Trial Update: Usefulness of Shirodhara for Insomnia [EARLY_Phase 1]
An early-phase clinical trial evaluating Shirodhara for insomnia has completed. The snippet does not report trial results.
-
CLINICAL_TRIALS withdrawal · 2012-09-07Clinical Trial Update: Xyrem for Treatment Refractory Insomnia Due to PTSD [Phase 2]
A Phase 2 trial evaluating Xyrem (sodium oxybate) for treatment-refractory insomnia associated with post-traumatic stress disorder has been …
-
CLINICAL_TRIALS trial_result · 2012-08-13Clinical Trial Update: To Evaluate The Effects Of SB-649868 (10, 30 Mg And 60 Mg) On Subjects With Primary Insomnia [Phase 2]
A Phase 2 clinical trial evaluating SB-649868 at 10, 30, and 60 mg in adults with primary insomnia has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: Cognitive Behavior Therapy for Insomnia in Primary Care [NA]
A completed clinical trial investigating cognitive behavioral therapy for insomnia delivered in primary care (sponsored by Uppsala Universit…
-
FDA approval · 2012-07-30FDA Approved: ZOLPIDEM TARTRATE — Original Application (Chartwell RX, LLC)
The FDA approved Chartwell RX, LLC's original application for zolpidem tartrate, a generic sleep medication for insomnia.
-
CLINICAL_TRIALS trial_result · 2012-07-25Clinical Trial Update: A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia [Phase 2]
This update reports that a Phase 2 randomized, double-blind, placebo-controlled trial of PD 0200390 in adults with primary insomnia has comp…
-
CLINICAL_TRIALS trial_result · 2012-07-25Clinical Trial Update: A Dose-ranging, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia [Phase 2]
Pfizer conducted a Phase 2 dose-ranging multicenter trial of PD 0200390 in adults with primary insomnia, and the study status is shown as co…
-
CLINICAL_TRIALS trial_result · 2012-07-24Clinical Trial Update: Sleep Self-Regulation Using Mental Imagery [NA]
A University of Auckland trial investigating sleep self-regulation using mental imagery has completed. It targets sleep deprivation and inso…
-
CLINICAL_TRIALS trial_result · 2012-07-11Clinical Trial Update: Behavioral Treatment of Insomnia in Aging [NA]
A completed clinical trial evaluating behavioral treatment for insomnia in aging individuals has been updated on ClinicalTrials.gov.
-
CLINICAL_TRIALS trial_result · 2012-07-02Clinical Trial Update: Melatonin for Sleep in Children With Autism [Phase 1]
A Phase 1 study evaluating melatonin for sleep in children with autism has completed, assessing safety and tolerability.
-
CLINICAL_TRIALS trial_result · 2012-06-29Clinical Trial Update: Ramelteon for Insomnia Comorbid With Asthma [Phase 3]
Phase 3 trial of ramelteon for insomnia in patients with comorbid asthma was terminated, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-06-29Clinical Trial Update: The Effects of Eszopiclone and Lexapro on Prefrontal Glutamate and GABA in Depression With Anxiety and Insomnia [Phase 4]
A Phase 4 trial evaluated the effects of eszopiclone and escitalopram (Lexapro) on prefrontal glutamate and GABA in adults with depression w…
-
FDA approval · 2012-06-28FDA Approved: PROMETHAZINE HYDROCHLORIDE — Original Application (Cranbury Pharmaceuticals, LLC)
The FDA approved Promethazine hydrochloride as an original generic drug application (ANDA) for Cranbury Pharmaceuticals, LLC.
-
FDA approval · 2012-06-22FDA Approved: TEMAZEPAM — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for Temazepam from Ascend Laboratories, LLC, authorizing a generic Temazepam product.
-
CLINICAL_TRIALS trial_result · 2012-06-18Clinical Trial Update: Brief Behavioral Treatment of Insomnia in Military Veterans: Phase 2 (BBTIMVII) [NA]
Phase 2 trial update for Brief Behavioral Treatment of Insomnia in military veterans (BBTIMVII) has completed, evaluating a non-pharmacologi…